{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-23-000017","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.995071+00:00","generated_at":"2026-06-18T04:14:24.331248+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Halozyme discloses minimal SVB exposure; deposits insured, custodial accounts at separate banks","bullets":["Cash deposit at SVB under $250,000 FDIC limit as of March 10, 2023.","Majority of cash and investments held in custodial accounts at independent institutions; SVB is agent only.","SVB is a lender on $575M credit facility with $39M commitment; no current draws and no plans to draw.","Treasury/Fed/FDIC joint statement ensures all depositors are fully protected; money available March 13."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-23-000017","json":"https://secwatch.observer/filing/0001159036-23-000017.json","markdown":"https://secwatch.observer/filing/0001159036-23-000017.md","text":"https://secwatch.observer/filing/0001159036-23-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903623000017/0001159036-23-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903623000017/halo-20230310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:14:24.331248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}